Latest Operational Efficiency News

Bathurst Resources reported a first half EBITDA of $27.5 million, surpassing forecasts despite export disruptions, yet lowered its full-year EBITDA guidance to $45-$55 million due to reduced export volumes and softer coal prices.

Resonance Health has reported record quarterly customer receipts of $5 million, a 57% increase from the previous quarter, alongside a major $13.8 million clinical trial contract win, signaling robust growth across its healthcare technology and clinical trial services.

Hydrix Limited reports back-to-back profitable quarters driven by strong margins and cost efficiencies, underpinned by a robust $40 million sales opportunity pipeline in cardiac and medtech sectors.

Bowen Coking Coal reported a strong December quarter with record coal sales and a 39% reduction in cash costs, underpinning a $29 million EBITDA despite softer coal prices.

XPON Technologies reports a modest 2% increase in martech revenue and a strong cash position for Q2 FY25, while navigating an 8% decline in annualised recurring revenue amid strategic sales recalibration.

Myer Holdings has completed its strategic acquisition of Just Group, adding five key apparel brands to its portfolio and issuing 890.5 million new shares to Premier Investments.

Pureprofile Limited has upgraded its FY25 financial guidance following a robust first half, highlighted by a 22% revenue increase and a 30% surge in Q2, driven by strong international expansion and automation adoption.

Metro Mining Limited delivered record bauxite shipments in Q4 2024, alongside a successful debt restructure and strong EBITDA margins, positioning the company for growth amid rising market prices.

Stellar Resources reports outstanding ore sorting results at its Heemskirk Tin Project, achieving a 2.4-fold increase in tin head grade and up to 95% tin recovery, promising significant cost savings and enhanced production potential.

Dimerix Limited has inked a lucrative licensing agreement with Fuso Pharmaceutical for its kidney disease drug DMX-200 in Japan, while completing recruitment for its pivotal Phase 3 ACTION3 trial.

Bellevue Gold Limited reports a robust December 2024 quarter with rising grades and tonnages, setting the stage for a significant production ramp-up and cost reductions in H2 FY25. The company also advances its commitment to sustainability, aiming for net-zero greenhouse gas emissions by 2026.

Sheffield Resources reported a record quarterly concentrate production of 198,704 tonnes at its Thunderbird mine, alongside a strategic expansion of its zircon concentrate customer base. Despite strong operational performance, the company faces short-term financial pressures amid restructuring efforts.